Related references
Note: Only part of the references are listed.Impact of macular fluid volume fluctuations on visual acuity during anti-VEGF therapy in eyes with nAMD
Usha Chakravarthy et al.
EYE (2021)
Association between early and late response in eyes with central or hemiretinal vein occlusion treated with anti-VEGF agents SCORE2 report 12: secondary analysis of the SCORE2 clinical trial
Rahul N. Khurana et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2021)
Ellipsoid Zone Defects in Retinal Vein Occlusion Correlates With Visual Acuity Prognosis: SCORE2 Report 14
Tyler Etheridge et al.
TRANSLATIONAL VISION SCIENCE & TECHNOLOGY (2021)
Associations of Variation in Retinal Thickness With Visual Acuity and Anatomic Outcomes in Eyes With Neovascular Age-Related Macular Degeneration Lesions Treated With Anti-Vascular Endothelial Growth Factor Agents
Rebecca N. Evans et al.
JAMA OPHTHALMOLOGY (2020)
Fluctuations in Macular Thickness in Patients with Retinal Vein Occlusion Treated with Anti-Vascular Endothelial Growth Factor Agents
Andrew X. Chen et al.
OPHTHALMOLOGY RETINA (2020)
Month 24 Outcomes After Treatment Initiation With Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal or Hemiretinal Vein Occlusion SCORE2 Report 10: A Secondary Analysis of the SCORE2 Randomized Clinical Trial
Ingrid U. Scott et al.
JAMA OPHTHALMOLOGY (2019)
Comparison of Monthly vs Treat-and-Extend Regimens for Individuals With Macular Edema Who Respond Well to Anti-Vascular Endothelial Growth Factor Medications Secondary Outcomes From the SCORE2 Randomized Clinical Trial
Ingrid U. Scott et al.
JAMA OPHTHALMOLOGY (2018)
Effect of Bevacizumab vs Aflibercept on Visual Acuity Among Patients With Macular Edema Due to Central Retinal Vein Occlusion The SCORE2 Randomized Clinical Trial
Ingrid U. Scott et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Study Design and Baseline Characteristics
Ingrid U. Scott et al.
OPHTHALMOLOGY (2017)
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
John A. Wells et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
被撤回的出版物: World Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects (Retracted article. See vol. 135, pg. 2149, 2021)
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration The CATT Research Group
Daniel F. Martin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Baseline Predictors of Visual Acuity and Retinal Thickness Outcomes in Patients with Retinal Vein Occlusion: Standard Care versus COrticosteroid for REtinal Vein Occlusion Study Report 10
Ingrid U. Scott et al.
OPHTHALMOLOGY (2011)
Share Paper
